[Effect of immunopotentiating agents (BCG, picibanil, and levamisole) and Maruyama vaccine on neutrophil functions including the generation of oxygen intermediates].
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000328:Adult; D001500:BCG Vaccine; D001688:Biological Products / Q000494:pharmacology*; D005260:Female; D005966:Glucuronidase / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D007978:Levamisole / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000201:enzymology / Q000378:metabolism* / Q000502:physiology; D010100:Oxygen / Q000378:metabolism*; D010587:Phagocytosis / Q000187:drug effects; D010844:Picibanil / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D001688:Biological Products; D007978:Levamisole; D010844:Picibanil; D005966:Glucuronidase; D010100:Oxygen